This peptidic drug is coformulated with sodium N-[8-(2-hydroxybenzoyl)amino]-caprylate, a gastric absorption enhancer, to promote oral bioavailability
These treatments decreased cell viability and increased both soluble and lipid reactive oxygen species (ROS) generation but did not affect mitochondrial ROS or mitochondrial mass
However, each combination can have different effects on the body, so it is best to consult a healthcare professional before use to ensure safety and optimal effectiveness
DAmbrosio V, Dore E, Di Blasi R, van den Broek M, Sudarsan S, Horst JT, Ambri F, Sommer MOA, Rugbjerg P, Keasling JD, Mans R, Jensen MK
It interacts with both IGF-1 receptors and insulin receptors, which are responsible for facilitating the uptake of glucose from the bloodstream into liver and muscle cells
Not dangerous but worth monitoring